Hyperion DeFi, Inc.
HYPD$2.66
+$0.32 (13.68%)
After HoursLoading chart...
IndexN/A
Market Cap0.01B
Enterprise Value0.02B
Income$-0.00B
Sales$0.00B
EmployeesN/A
P/E-0.24
P/S21.88
P/B0.43
P/C-1.21
EV/EBITDA-0.45
EV/SalesN/A
EPS (ttm)-11.03
EarningsN/A
Gross Margin62.72%
Oper. Margin-2333.42%
Profit Margin-5570.61%
Volume0.21M
Shs Outstand0.00B
Change13.68%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
Yesterday10:21AMHyperion DeFi Schedules First Quarter Earnings Call for Wednesday, August 12 at 5:00 p.m. ET(globenewswire.com)10:21AMHyperion DeFi Schedules First Quarter Earnings Call for Wednesday, August 12 at 5:00 p.m. ET(globenewswire.com)
Jun 808:00AMHyperion DeFi Reiterates Guidance on Sunset of USDH and Felix Markets(globenewswire.com)
May 1411:50AMHyperion DeFi, Inc. (HYPD) Q1 2026 Earnings Call Transcript(seekingalpha.com)07:00AMHyperion DeFi Reports 1Q 2026 Financial Results with Record Net Income and Raises Guidance for Full Year 2026(globenewswire.com)
Mar 2611:46AMHyperion DeFi, Inc. (HYPD) Q4 2025 Earnings Call Transcript(seekingalpha.com)07:00AMHyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit(globenewswire.com)
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Revenue | $57.34K | $3.79K | N/A | $14.00M | $2.00M |
| Cost of Revenue | $3.93M | $16.00K | N/A | $1.60M | $800.00K |
| Gross Profit | $-3.87M | $-12.22K | N/A | $12.40M | $1.20M |
| Gross Margin | -6749.50% | -322.63% | 0.00% | 88.57% | 60.00% |
| Operating Expenses | $44.87M | $25.39M | $26.91M | $25.42M | $20.99M |
| Operating Income | $-48.74M | $-25.41M | $-26.91M | $-13.02M | $-19.79M |
| Operating Margin | -85004.58% | -670885.82% | 0.00% | -93.00% | -989.46% |
| Net Income | $-49.82M | $-27.26M | $-28.01M | $-12.78M | $-19.77M |
| Net Margin | -86888.57% | -719859.94% | 0.00% | -91.27% | -988.49% |
| EPS (Basic) | $-59.81 | $-53.15 | $-66.40 | $-39.20 | $-75.12 |
| EBITDA | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Discover more
You may be interested in